NLRP3 and endothelial dysfunction: We demonstrated that AE inhibited the NLRP3 signaling pathway to alleviate endothelial dysfunction because ZO‐1/2 of gNLRP3 cells has no significant change in the normal group, model group, or administration group (Fig. 5B–E).